Clinical Trial Update: Assessment of CataClear, Tear Film Stability, Tear Volume, and Dry Eye Symptoms Using Stem Cells Fortified Eye Drops [Phase 4]

View source ↗

Summary

This clinical trial update reports ongoing Phase 4 recruitment for CataClear, a stem cell fortified eye drop, evaluating tear film stability, tear volume, and d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Dry Eye

Drugs mentioned

• CataClear

Snippet

Sponsor: Ace Cells Lab Limited | Conditions: Dry Eye, Cataract | Phase 4 | Status: RECRUITING